Poolbeg Pharma Income Statement

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Selling, General & Admin	4.89	5.26	3.38	3.06	2.71
Research & Development	1.53	1.38	1.68	2.2	0.55
Other Operating Expenses	-0.42	-0.53	-0.37	-0.28	-0.15
Operating Expenses	6	6.11	4.69	4.99	3.11
Operating Income	-6	-6.11	-4.69	-4.99	-3.11
Interest & Investment Income	-	0.43	0.53	0.21	-
Other Non Operating Income (Expenses)	0.25	-	-	-	-
EBT Excluding Unusual Items	-5.74	-5.68	-4.15	-4.78	-3.11
Gain (Loss) on Sale of Assets	-0.01	-0.26	-	-	-
Asset Writedown	-0.03	-	-0.35	-	-
Pretax Income	-5.77	-5.94	-4.51	-4.78	-3.11
Income Tax Expense	-0.08	-0.15	-0.57	-0.09	-
Net Income	-5.7	-5.79	-3.93	-4.69	-3.11
Net Income to Common	-5.7	-5.79	-3.93	-4.69	-3.11
Shares Outstanding (Basic)	606	500	500	500	317
Shares Outstanding (Diluted)	606	500	500	500	317
Shares Change (YoY)	21.17%	-	-	57.62%	-
EPS (Basic)	-0.01	-0.01	-0.01	-0.01	-0.01
EPS (Diluted)	-0.01	-0.01	-0.01	-0.01	-0.01
EBITDA	-5.94	-6	-4.66	-4.96	-3.09
D&A For EBITDA	0.06	0.11	0.03	0.03	0.02
EBIT	-6	-6.11	-4.69	-4.99	-3.11

Source: S&P Global Market Intelligence. Standard template. Financial Sources.